Regulatory BCL2 promoter polymorphism (−938C>A) is...

International Journal of Cancer 2011 Vol. 129; Iss. 10

Regulatory BCL2 promoter polymorphism (−938C>A) is associated with adverse outcome in patients with prostate carcinoma

Hagen S. Bachmann, Lukas C. Heukamp, Klaus J. Schmitz, Caroline F. Hilburn, Philip Kahl, Reinhard Buettner, Holger Nückel, Andreas Eisenhardt, Herbert Rübben, Kurt Werner Schmid, Winfried Siffert, Ang
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
129
Year:
2011
Language:
english
Pages:
10
DOI:
10.1002/ijc.25904
File:
PDF, 539 KB
english, 2011
Conversion to is in progress
Conversion to is failed